HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells.

Abstract
2-Methoxyestradiol (2-ME), an endogenous derivative of 17β-estradiol, has been reported to elicit antiproliferative responses in various tumors. In this study, we investigated the effects of 2-ME on cell viability, proliferation, cell cycle, and apoptosis in human urothelial carcinoma (UC) cell lines. We used two high-grade human bladder UC cell lines (NTUB1 and T24). After treatment with 2-ME, the cell viability and apoptosis were measured by MTT assay and flow cytometry (fluorescence-activated cell sorting), with annexin V-FITC staining and propidium iodide (PI) labeling. DNA fragmentation was analyzed by agarose gel electrophoresis. Flow cytometry with PI labeling was used for the cell cycle analyses. The protein levels of caspase activations, poly (ADP-ribose) polymerase (PARP) cleavage, phospho-histone H2A.X, phospho-Bad, and cell cycle regulatory molecules were measured by Western blot. The effects of the drug combinations were analyzed using the computer software, CalcuSyn. We demonstrated that 2-ME effectively induces dose-dependent cytotoxicity and apoptosis in human UC cells after 24 h exposure. DNA fragmentation, PARP cleavage, and caspase-3, 7, 8, 9 activations can be observed with 2-ME-induced apoptosis. The decreased phospho-Bad (Ser136 and Ser155) and mitotic arrest of the cell cycle in the process of apoptosis after 2-ME treatment was remarkable. In response to mitotic arrest, the mitotic forms of cdc25C, phospho-cdc2, cyclin B1, and phospho-histone H3 (Ser10) were activated. In combination with arsenic trioxide (As2O3), 2-ME elicited synergistic cytotoxicity (combination index <1) in UC cells. We concluded that 2-ME significantly induces apoptosis through decreased phospho-Bad and arrests bladder UC cells at the mitotic phase. The synergistic antitumor effect with As2O3 provides a novel implication in clinical treatment of UC.
AuthorsKuan-Lin Kuo, Wei-Chou Lin, I-Lin Ho, Hong-Chiang Chang, Ping-Yi Lee, Yuan-Ting Chung, Ju-Ton Hsieh, Yeong-Shiau Pu, Chung-Sheng Shi, Kuo-How Huang
JournalPloS one (PLoS One) Vol. 8 Issue 8 Pg. e68703 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23967052 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arsenicals
  • Histones
  • Oxides
  • bcl-Associated Death Protein
  • Estradiol
  • 2-Methoxyestradiol
  • Poly(ADP-ribose) Polymerases
  • Caspases
  • Arsenic Trioxide
Topics
  • 2-Methoxyestradiol
  • Aged
  • Apoptosis (drug effects)
  • Arsenic Trioxide
  • Arsenicals (pharmacology)
  • Caspases (metabolism)
  • Cell Cycle Checkpoints (drug effects)
  • Cell Line, Transformed
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • DNA Fragmentation (drug effects)
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Enzyme Activation (drug effects)
  • Estradiol (analogs & derivatives, pharmacology, toxicity)
  • Female
  • Histones (metabolism)
  • Humans
  • Mitosis (drug effects)
  • Oxides (pharmacology, toxicity)
  • Phosphorylation (drug effects)
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Urologic Neoplasms (metabolism)
  • bcl-Associated Death Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: